Copyright Reports & Markets. All rights reserved.

Global OAB Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of OAB Treatment by Type
    • 1.3.1 Overview: Global OAB Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global OAB Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Anticholinergics
    • 1.3.4 Mirabegron
    • 1.3.5 Botox
    • 1.3.6 Others
  • 1.4 Global OAB Treatment Market by Application
    • 1.4.1 Overview: Global OAB Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Idiopathic Overactive Bladder
    • 1.4.3 Neurogenic Overactive Bladder
  • 1.5 Global OAB Treatment Market Size & Forecast
  • 1.6 Global OAB Treatment Market Size and Forecast by Region
    • 1.6.1 Global OAB Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global OAB Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America OAB Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe OAB Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific OAB Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America OAB Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa OAB Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie OAB Treatment Product and Solutions
    • 2.1.4 AbbVie OAB Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 Astellas Pharma
    • 2.2.1 Astellas Pharma Details
    • 2.2.2 Astellas Pharma Major Business
    • 2.2.3 Astellas Pharma OAB Treatment Product and Solutions
    • 2.2.4 Astellas Pharma OAB Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Astellas Pharma Recent Developments and Future Plans
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer OAB Treatment Product and Solutions
    • 2.3.4 Pfizer OAB Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Pfizer Recent Developments and Future Plans
  • 2.4 Teva
    • 2.4.1 Teva Details
    • 2.4.2 Teva Major Business
    • 2.4.3 Teva OAB Treatment Product and Solutions
    • 2.4.4 Teva OAB Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Teva Recent Developments and Future Plans
  • 2.5 Johnson & Johnson
    • 2.5.1 Johnson & Johnson Details
    • 2.5.2 Johnson & Johnson Major Business
    • 2.5.3 Johnson & Johnson OAB Treatment Product and Solutions
    • 2.5.4 Johnson & Johnson OAB Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.6 Kyorin Pharmaceutical
    • 2.6.1 Kyorin Pharmaceutical Details
    • 2.6.2 Kyorin Pharmaceutical Major Business
    • 2.6.3 Kyorin Pharmaceutical OAB Treatment Product and Solutions
    • 2.6.4 Kyorin Pharmaceutical OAB Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Kyorin Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global OAB Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of OAB Treatment by Company Revenue
    • 3.2.2 Top 3 OAB Treatment Players Market Share in 2023
    • 3.2.3 Top 6 OAB Treatment Players Market Share in 2023
  • 3.3 OAB Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 OAB Treatment Market: Region Footprint
    • 3.3.2 OAB Treatment Market: Company Product Type Footprint
    • 3.3.3 OAB Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global OAB Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global OAB Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global OAB Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global OAB Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America OAB Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America OAB Treatment Market Size by Application (2019-2030)
  • 6.3 North America OAB Treatment Market Size by Country
    • 6.3.1 North America OAB Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States OAB Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada OAB Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico OAB Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe OAB Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe OAB Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe OAB Treatment Market Size by Country
    • 7.3.1 Europe OAB Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany OAB Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France OAB Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom OAB Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia OAB Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy OAB Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific OAB Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific OAB Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific OAB Treatment Market Size by Region
    • 8.3.1 Asia-Pacific OAB Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China OAB Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan OAB Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea OAB Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India OAB Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia OAB Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia OAB Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America OAB Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America OAB Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America OAB Treatment Market Size by Country
    • 9.3.1 South America OAB Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil OAB Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina OAB Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa OAB Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa OAB Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa OAB Treatment Market Size by Country
    • 10.3.1 Middle East & Africa OAB Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey OAB Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia OAB Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE OAB Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 OAB Treatment Market Drivers
  • 11.2 OAB Treatment Market Restraints
  • 11.3 OAB Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 OAB Treatment Industry Chain
  • 12.2 OAB Treatment Upstream Analysis
  • 12.3 OAB Treatment Midstream Analysis
  • 12.4 OAB Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global OAB Treatment market size was valued at US$ 5175 million in 2023 and is forecast to a readjusted size of USD 5711 million by 2030 with a CAGR of 1.4% during review period.
    AbbVie is the largest producer of OAB treatment worldwide, holding over 40% of the overall market share. North America is currently the largest consumption market in the world, with over 50% of the market, followed by Europe and Japan.
    This report is a detailed and comprehensive analysis for global OAB Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global OAB Treatment market size and forecasts, in consumption value ($ Million), 2019-2030
    Global OAB Treatment market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global OAB Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global OAB Treatment market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for OAB Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global OAB Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Astellas Pharma, Pfizer, Teva, Johnson & Johnson, Kyorin Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    OAB Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    OAB Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Anticholinergics
    Mirabegron
    Botox
    Others
    Market segment by Application
    Idiopathic Overactive Bladder
    Neurogenic Overactive Bladder
    Market segment by players, this report covers
    AbbVie
    Astellas Pharma
    Pfizer
    Teva
    Johnson & Johnson
    Kyorin Pharmaceutical
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe OAB Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of OAB Treatment, with revenue, gross margin, and global market share of OAB Treatment from 2019 to 2024.
    Chapter 3, the OAB Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and OAB Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of OAB Treatment.
    Chapter 13, to describe OAB Treatment research findings and conclusion.

    Buy now